Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.02 USD | +2.11% | +3.51% | -11.96% |
01:08pm | Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens | MT |
May. 06 | Bausch + Lomb Shares Rise After Morgan Stanley Upgrade | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.96% | 5.28B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.49% | 40.74B | |
+21.98% | 31.6B | |
+16.38% | 25.56B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16